Cassava Sciences

Halal Rating :
To Be Determined
See Details
Last Price $19.50 Last updated:
Market Cap $1.08b
7D Change -0.05%
1 Year Change -0.05%

Company Overview

  • Pharmaceuticals: Other
  • Health Technology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 28, 2024

Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $2.35m $29.57m $1.58m $2.63m 67.25% 8.90%

Company Impact

Help us evaluate Cassava Sciences's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates